Fair Value
- Price
- $3.92
- Fair value
- $128
- Typical P/S, 20y
- 7.1x
- Revenue/share growth rate
- -34.7%
- Trailing 12M revenue/share
- —
Results are highly cyclical for SONM, so multiple-based fair value is less reliable here.
| FY | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| High | — | 6930 | 2808 | 252 | 225 | 187 | 68.04 |
| Low | — | 794 | 161 | 73.49 | 75.60 | 43.20 | 2.75 |
| Rev/Sh | 673.03 | 99.07 | 65.11 | 17.07 | 23.72 | 11.74 | 18.02 |
| Chg/Yr | — | -85% | -34% | -74% | +39% | -51% | +54% |
| Div | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
How these numbers are calculated
Fair value (7.1x sales) multiplies each year's revenue per share by the price-to-sales ratio investors have typically paid for SONM — the median of the last 20 fiscal years' average price over that year's revenue per share. The line extends forward with analyst revenue estimates (dashed).
Revenue comes from reported quarters; share counts come from market value divided by the share price, so buybacks and splits are handled correctly. The verdict calls a stock over- or undervalued only when the price sits more than 10% from the line.
Explore More
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
